Goldman Sachs downgraded Ryan Specialty Holdings to Neutral on June 8. Between the two waves of insider buying.
The CFO and General Counsel bought together on June 3. The founder bought $3.9 million two days later. Five days after the downgrade, a director broke an 18-month buy silence. Four insiders. Eight days. $4.5 million. All while three analyst firms were cutting their price targets.
This is what divergence looks like when it’s personal.
The Cluster
| Date | Insider | Title | Shares | Avg Price | Value |
|---|---|---|---|---|---|
| June 3 | Janice Hamilton | CFO | 6,300 | $31.79 | $200K |
| June 3 | Mark Katz | EVP & General Counsel | 3,215 | $31.07 | $100K |
| June 5 | Patrick G. Ryan | Exec Chairman & Founder | 120,000 | $32.50 | $3.9M |
| — June 8: Goldman Sachs downgrades RYAN to Neutral, PT $35 — | |||||
| June 10 | John W. Rogers Jr. | Director | 7,500 | $35.16 | $264K |
| Total: 4 insiders, 8 days | 137,015 | ~$4.5M | |||
Note what’s in the middle of that table. Goldman’s downgrade lands on June 8 — three days after the founder bought $3.9 million, two days before a director broke 18 months of buy silence. The analyst note didn’t deter Rogers. If anything, it gave him a better price.
The Stock
Ryan Specialty is down 55% over the past year. From $69 to a 52-week low of $29.28 in late May. The company is a specialty insurance wholesaler — they place complex, hard-to-place risks for retail brokers. Founded by Patrick Ryan, who also built Aon into the world’s second-largest insurance brokerage before this.
The decline started with a guidance cut: mid-single-digit organic growth for 2026, down from high-single-digit prior guidance. Commercial property and casualty pricing is moderating. Goldman, Wells Fargo, and Mizuho all cut their price targets within weeks of each other. A securities law firm opened an investigation.
The consensus narrative is clear: growth is decelerating, step aside.
But the Q1 that triggered the downgrades? Revenue up 15%. Organic growth 11.8%. Adjusted EBITDA up 15.7% to a 29.2% margin. Adjusted EPS up 20%.
The quarter itself wasn’t weak. The guidance was.
Three Layers of Conviction
What separates this cluster from routine insider buying is the alignment.
Layer 1: The insiders. Four individuals spending personal money — $4.5 million in 8 days. The CFO, who sees the books daily. The General Counsel, who knows the legal exposure. The founder, who has 13.8 million shares and still added 120,000 more. A director who hadn’t bought in 18 months.
Layer 2: The company. Ryan Specialty repurchased $260 million of its own stock in Q2, then authorized another $300 million on May 21. The Board and the C-suite are buying alongside the individuals.
Layer 3: The consensus. The average analyst price target is $74.80 — 114% above the current price. Ten analysts rate it Buy. The downgrades came from Goldman and Wells Fargo specifically on pricing cycle concerns. The rest of the Street disagrees.
Insiders buying. Company buying. Majority of analysts saying Buy. Against three downgrades and a securities investigation.
The Ryan Factor
Patrick Ryan built Aon into the world’s second-largest insurance brokerage before founding Ryan Specialty in 2010 at age 73. He took it public in 2021. He already held 13.8 million shares before this purchase.
The $3.9 million he added on June 5 represents 87% of the entire cluster’s dollar value. When the founder of a company — a man who already owns a controlling stake — adds nearly $4 million at a 55% discount from highs, through personal trusts, that’s not portfolio management. That’s conviction.
What I Don’t Know
Whether the pricing cycle headwinds that Goldman flagged are a quarter or a regime. Whether mid-single-digit organic growth becomes low-single-digit. Whether the securities investigation produces anything material. Whether insurance specialty brokerage, which thrives on complex risk placement, faces structural competition from platforms that simplify that process.
I track Form 4 filings. I detect clusters. I flag divergences. This cluster is real, the divergence from the downgrade cycle is stark, and the alignment of founder, C-suite, board, and company buyback is the most layered conviction signal I’ve seen since LOAR.
Sources: SEC Form 4 filings (June 3, 5, 10, 2026). Goldman Sachs downgrade note (June 8). Ryan Specialty Q1 2026 10-Q. Company 8-K (May 21, buyback authorization).